CompletedPhase 1NCT01527838

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fate Therapeutics
Principal Investigator
Samuel Dychter, MD
Fate Therapeutics
Intervention
Single FT1050 treated UCB unit(biological)
Enrollment
10 enrolled
Eligibility
18-65 years · All sexes
Timeline
20122013

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01527838 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials